课题基金 / 基金详情

Biochemistry and Signaling of Receptor for Advanced Glycation End Products

Biochemistry and Signaling of Receptor for Advanced Glycation End Products
高级糖基化终产物受体的生物化学和信号传导
批准号:
8335931
负责人:
Edward Lakatta
金额:
$10.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Edward Lakatta的其他基金

相似基金

相关文献

中文摘要
翻译
细胞信号通过晚期糖基化终产物受体(RAGE)导致促炎反应。rage介导的炎症与炎症性疾病有关,包括糖尿病、动脉粥样硬化、阿尔茨海默病。在生物化学部分,我们已经确定了介导RAGE寡聚化和调节RAGE在细胞表面表达的关键结构元件。我们还通过蛋白质组学完成了RAGE细胞表面复合体的初步研究。通过与能源部洛斯阿拉莫斯国家实验室的科学家合作,我们还开发了分裂GFP标记技术,该技术可广泛用于研究其他哺乳动物膜蛋白的寡聚化。该技术将进一步发展,以研究RAGE信号。我们还与澳大利亚新南威尔士大学的科学家合作,研究RAGE细胞表面硫醇-二硫交换的分子机制。
英文摘要
Cellular signaling via receptor for advanced glycation end products (RAGE) results in pro-inflammatory responses. RAGE-mediated inflammation has been implicated in inflammatory diseases including diabetes, atherosclerosis, Alzheimers disease. In the biochemistry part, we have identified critical structural elements that mediate RAGE oligomerization and regulate RAGE expression on the cell surface. We have also completed a preliminary study of RAGE cell surface complex via proteomics. In collaboration with scientists in the Department of Energy's Los Alamos National Lab, we have also developed split GFP tagging technology that can be broadly used to study oligomerization of other mammalian membrane proteins. The technology will be further developed to study RAGE signaling. We also collaborate with scientists in University of New South Wales, Australia, to study the molecular mechanism of RAGE thiol-disulfide exchanges on the cell surface.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PUFA Dietary Intervention for Heart Rate
  • 批准号:
    8335786
  • 项目类别:
  • 资助金额:
    $25.83万
  • 财政年份:
    --
  • 负责人:
    Edward Lakatta
  • 依托单位:
Decreased pacemaker activity in aged sinoatrial node
  • 批准号:
    8335801
  • 项目类别:
  • 资助金额:
    $11.03万
  • 财政年份:
    --
  • 负责人:
    Edward Lakatta
  • 依托单位:
Soluble Receptor for Advanced Glycation End Products for Therapeutic Application
  • 批准号:
    8552494
  • 项目类别:
  • 资助金额:
    $12.3万
  • 财政年份:
    --
  • 负责人:
    Edward Lakatta
  • 依托单位:
Therapeutic Potential of EPO and its Derivatives for Reducing Blood Pressure
  • 批准号:
    9147229
  • 项目类别:
  • 资助金额:
    $15.43万
  • 财政年份:
    --
  • 负责人:
    Edward Lakatta
  • 依托单位:
海外基金